$ATEN
A10 Networks, Inc.

2015 Q1 Form 10-Q Financial Statement

#000158080815000018 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $44.02M $45.75M
YoY Change -3.78% 54.64%
Cost Of Revenue $10.79M $10.05M
YoY Change 7.29% 52.23%
Gross Profit $33.23M $35.69M
YoY Change -6.9% 55.34%
Gross Profit Margin 75.5% 78.02%
Selling, General & Admin $32.05M $26.93M
YoY Change 19.03% 38.66%
% of Gross Profit 96.44% 75.44%
Research & Development $14.31M $11.21M
YoY Change 27.7% 44.17%
% of Gross Profit 43.06% 31.39%
Depreciation & Amortization $2.500M $2.200M
YoY Change 13.64% 69.23%
% of Gross Profit 7.52% 6.16%
Operating Expenses $46.80M $39.98M
YoY Change 17.07% 30.67%
Operating Profit -$13.57M -$4.285M
YoY Change 216.73% -43.75%
Interest Expense $127.0K $587.0K
YoY Change -78.36% 4415.38%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$612.0K
YoY Change -83.66% -11.82%
Pretax Income -$13.67M -$4.897M
YoY Change 179.19% -41.09%
Income Tax $62.00K $205.0K
% Of Pretax Income
Net Earnings -$13.73M -$5.102M
YoY Change 169.19% -40.21%
Net Earnings / Revenue -31.2% -11.15%
Basic Earnings Per Share -$0.22 -$0.45
Diluted Earnings Per Share -$0.22 -$0.45
COMMON SHARES
Basic Shares Outstanding 61.49M shares 13.94M shares
Diluted Shares Outstanding 61.49M shares 13.94M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $85.60M $122.1M
YoY Change -29.89%
Cash & Equivalents $85.57M $122.1M
Short-Term Investments
Other Short-Term Assets $4.200M $3.500M
YoY Change 20.0%
Inventory $19.77M $17.54M
Prepaid Expenses
Receivables $52.76M $38.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $162.3M $182.0M
YoY Change -10.81%
LONG-TERM ASSETS
Property, Plant & Equipment $9.951M $11.25M
YoY Change -11.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.695M $3.855M
YoY Change 21.79%
Total Long-Term Assets $14.65M $16.13M
YoY Change -9.19%
TOTAL ASSETS
Total Short-Term Assets $162.3M $182.0M
Total Long-Term Assets $14.65M $16.13M
Total Assets $176.9M $198.1M
YoY Change -10.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.989M $9.464M
YoY Change -15.59%
Accrued Expenses $19.85M $17.99M
YoY Change 10.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.99M $68.73M
YoY Change -1.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.557M $2.443M
YoY Change -36.27%
Total Long-Term Liabilities $1.557M $2.443M
YoY Change -36.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.99M $68.73M
Total Long-Term Liabilities $1.557M $2.443M
Total Liabilities $89.06M $87.98M
YoY Change 1.23%
SHAREHOLDERS EQUITY
Retained Earnings -$195.5M -$152.2M
YoY Change 28.49%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $87.89M $110.1M
YoY Change
Total Liabilities & Shareholders Equity $176.9M $198.1M
YoY Change -10.68%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$13.73M -$5.102M
YoY Change 169.19% -40.21%
Depreciation, Depletion And Amortization $2.500M $2.200M
YoY Change 13.64% 69.23%
Cash From Operating Activities -$5.498M -$2.971M
YoY Change 85.06% -63.31%
INVESTING ACTIVITIES
Capital Expenditures $901.0K $2.022M
YoY Change -55.44% 185.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$901.0K -$2.022M
YoY Change -55.44% 185.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $64.00K -$2.248M
YoY Change -102.85%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $64.00K $106.3M
YoY Change -99.94% 10135.71%
NET CHANGE
Cash From Operating Activities -$5.498M -$2.971M
Cash From Investing Activities -$901.0K -$2.022M
Cash From Financing Activities $64.00K $106.3M
Net Change In Cash -$6.335M $101.4M
YoY Change -106.25% -1404.96%
FREE CASH FLOW
Cash From Operating Activities -$5.498M -$2.971M
Capital Expenditures $901.0K $2.022M
Free Cash Flow -$6.399M -$4.993M
YoY Change 28.16% -43.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-25000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8994000 USD
CY2015Q1 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
27000 USD
CY2014Q1 aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
124177000 USD
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61617622 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2015Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
CY2015Q1 dei Trading Symbol
TradingSymbol
ATEN
CY2014Q1 aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
1429000 USD
CY2015Q1 aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
0 USD
CY2015Q1 aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
0 USD
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7989000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54003000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52762000 USD
CY2014Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
400000 USD
CY2015Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
800000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22435000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19850000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25744000 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28081000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278349000 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283408000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3246000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2775000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10278000 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11435000 shares
CY2014Q4 us-gaap Assets
Assets
186980000 USD
CY2015Q1 us-gaap Assets
Assets
176946000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
171341000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
162300000 USD
CY2012Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
800000 USD
CY2015Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
300000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20793000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122149000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91905000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85570000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
101356000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6335000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61377000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61593000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61377000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61593000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10053000 USD
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10786000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7427000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7063000 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
2626000 USD
CY2015Q1 us-gaap Cost Of Services
CostOfServices
3723000 USD
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
57220000 USD
CY2015Q1 us-gaap Deferred Revenue
DeferredRevenue
59660000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39256000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
40155000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
17964000 USD
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
19505000 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2247000 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2489000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14447000 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13184000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30700000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M20D
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
178000 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
162000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5363000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7527000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
35692000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
33231000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4897000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13672000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
205000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-341000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-987000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1241000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1311000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
870000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2639000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2714000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2438000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1785000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-185000 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-89000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-115000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2277000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-709000 USD
CY2014Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2014Q1 us-gaap Interest Expense
InterestExpense
587000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
127000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10779000 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11867000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
20701000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
19768000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9922000 USD
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
7901000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
90415000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
89056000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186980000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176946000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
70685000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67994000 USD
CY2014Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1846000 USD
CY2015Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
445000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106349000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2022000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-901000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2971000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5498000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-5102000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-13734000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6252000 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13734000 USD
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
11777000 USD
CY2015Q1 us-gaap Noncurrent Assets
NoncurrentAssets
10922000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-612000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
39977000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
46803000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4285000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13572000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5434000 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4357000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4859000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4695000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1766000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1557000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2022000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
901000 USD
CY2014Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1150000 USD
CY2015Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4732000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4200000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-2248000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-64000 USD
CY2014Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-76000 USD
CY2015Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36524000 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38032000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10780000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9951000 USD
CY2014Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1416000 USD
CY2015Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
747000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
263000 USD
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
144000 USD
CY2014Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
CY2015Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015Q1 us-gaap Revenues
Revenues
44017000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11205000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14309000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-181785000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-195519000 USD
CY2014Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
600000 USD
CY2015Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1400000 USD
CY2014Q1 us-gaap Revenues
Revenues
45745000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36417000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
30516000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
45745000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
44017000 USD
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9328000 USD
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
13501000 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21563000 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24522000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1770000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4633000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6692000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
537000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
415000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
149000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.97
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.05
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7521000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11084000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10652000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.18
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.15
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
7368000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5118000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.97
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
7518000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10091000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.10
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.59
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.32
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.67
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y2M4D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M21D
CY2014Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7071000 USD
CY2015Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
305000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
166000 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
96565000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
87890000 USD
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2554000 USD
CY2015Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2309000 USD
CY2014Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-1150000 USD
CY2015Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2200000 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2300000 USD
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13940000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61485000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13940000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61485000 shares
CY2015Q1 us-gaap Year Founded
YearFounded
2004
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. Our cash and cash equivalents are invested in high-credit quality financial instruments with banks and financial institutions. Management believes that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, are subject to minimal credit risk. Such deposits may be in excess of insured limits provided on such deposits.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations of our customers to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenue for each period presented or our gross accounts receivable balance as of each respective balance sheet date.</font></div></div>
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, sales return reserve, valuation of inventory, contingencies and litigation, and determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>

Files In Submission

Name View Source Status
0001580808-15-000018-index-headers.html Edgar Link pending
0001580808-15-000018-index.html Edgar Link pending
0001580808-15-000018.txt Edgar Link pending
0001580808-15-000018-xbrl.zip Edgar Link pending
aten-20150331.xml Edgar Link completed
aten-20150331.xsd Edgar Link pending
aten-20150331_cal.xml Edgar Link unprocessable
aten-20150331_def.xml Edgar Link unprocessable
aten-20150331_lab.xml Edgar Link unprocessable
aten-20150331_pre.xml Edgar Link unprocessable
aten-2015331x10q.htm Edgar Link pending
exhibit3112015331.htm Edgar Link pending
exhibit3122015331.htm Edgar Link pending
exhibit3212015331.htm Edgar Link pending
exhibit3222015331.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending